Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Dec 9;28(3):337–349. doi: 10.1016/0165-2427(91)90125-V

In vitro mitogen responses and lymphocyte subpopulations in cheetahs

M Miller-Edge 1, M Worley 1,1
PMCID: PMC7119974  PMID: 1835214

Abstract

Lack of genetic variability and apparent susceptibility of cheetahs (Acinonyx jubatus) to coronavirus infection has lead to speculation that this species may have immune system deficits. To establish a foundation for evaluation of the immune function, cheetah peripheral blood mononuclear cells (PBM) were stimulated by a panel of six mitogens, and responses compared with those of domestic cat PBM. Individual responses in both species were variable, but evenly distributed throughout the range of stimulation for each mitogen. Proliferation by PBM from domestic cats occured within the same range as that of the cheetahs. However, a significantly lower response to peanut agglutinin (PNA) was observed with domestic cat PBM.

Although responses varied between animals, certain individual cheetahs were consistent responders. The decreased values could not be explained by lack of IL-2 responsiveness since exogenous IL-2 significantly enhanced mitogen-stimulated proliferation in 11 of 12 cheetahs tested.

The phenotypic distribution of domestic cat and cheetah lymphocyte subpopulations was similar as assessed by immunofluorescence staining for surface immunoglobulin (sIg) and cytotoxic T (Tc) cells (using a specific monoclonal antibody, FT2). Values for B cells (31.2% sIg+) and Tc (28.7% FT2 +) were slightly higher in domestic cats as compared with cheetah PBM (13.3% sIg+; 19.0% FT2+). Even though no species-specific deficits were detected, a significant negative correlation between PHA-stimulated proliferation and percent FT2+ (Tc) cheetah cells was observed. This indicates that proliferation can be used indirectly to assess relative numbers of functional T helper cells in cheetahs. Our studies suggest that these aspects of the cheetah's immune system are comparable with the domestic cat, and establish a basis for in vitro assays evaluating antigen-specific responses.

Abbreviations: ACD, acid citric dextrose; Con A, concanavalin A; ELISA, enzyme-linked immunosorbent assay; FeLV, feline leukemia virus; FHV-1, feline herpes virus; FIPV, feline infectious peritonitis coronavirus; FITC, fluorescein isothiocynate; MASH, multiple automated sample harvester; MHC, major histocompatibility complex; PBM, peripheral blood mononuclear cells; PBS, phosphate-buffered saline; PHA, phytohaemagglutinin; PMT, photon multiplier tube; PNA, peanut agglutinin; PWM, pokeweed mitogen; SBA, soybean agglutinin; SCM, serum containing medium; WGA, wheatgerm agglutinin

References

  1. Alcocer-Varela J., Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 1982;69:1388–1392. doi: 10.1172/JCI110579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briggs M.B., Ott R.L. Feline leukemia virus infection in a captive cheetah and the clinical and antibody response of six captive cheetahs to vaccination with a subunit feline leukemia virus vaccine. J. Am. Vet. Med. Assoc. 1986;189:1197–1199. [PubMed] [Google Scholar]
  3. Chudwin D.S., Cowen M.J., Wara D.W., Ammann A.J. Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity. Clin. Immunol. Immunopathol. 1983;26:126–136. doi: 10.1016/0090-1229(83)90181-2. [DOI] [PubMed] [Google Scholar]
  4. Cockerell G.L., Hoover E.A., LoBugilo A.F., Yohn D.S. Phytomitogen- and antigen-induced blast transformation of feline lymphocytes. Am. J. Vet. Res. 1975;36:1489–1494. [PubMed] [Google Scholar]
  5. Effros R.B., Walford R.L. The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cell. Immunol. 1983;81:298–305. doi: 10.1016/0008-8749(83)90237-x. [DOI] [PubMed] [Google Scholar]
  6. Evermann J.F., Roelke M.E., Briggs M.B. Clinical and diagnostic features of feline coronavirus infections of cheetahs. Feline Pract. 1986;16:21–30. [Google Scholar]
  7. Evermann J.F., Heeney J.L., Roelke M.E., McKeirnan A.J., O'Brien S.J. Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah. Arch. Virol. 1988;102:155–171. doi: 10.1007/BF01310822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilman S.C., Rosenberg J.S., Feldman J.D. T lymphocytes of young and aged rats. II. Functional defects and the role of interleukin-2. J. Immunol. 1982;128:644–650. [PubMed] [Google Scholar]
  9. Ilonen J., Salmi A. Detection of antigen-specific cellular immune response by the in vitro production of T-cell growth factor. Scand. J. Immunol. 1982;15:521–524. doi: 10.1111/j.1365-3083.1982.tb00679.x. [DOI] [PubMed] [Google Scholar]
  10. Klotz F.W., Cooper M.D. A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity. J. Immunol. 1986;136:2510–2514. [PubMed] [Google Scholar]
  11. Kuramochi T., Takeishi T., Ishida T., Kato K., Ishida M. Characterization of feline T and B cells. Am. J. Vet. Res. 1987;48:183–185. [PubMed] [Google Scholar]
  12. Larsson E.-L. Mechanism of T cell activation. II. Antigen-and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells. J. Immunol. 1981;126:1323–1326. [PubMed] [Google Scholar]
  13. Lopez-Botet M., Fontan G., Garcia Rodriguez M.C., de Landazuri M.O. Relationship between IL-2 synthesis and the proliferative response to PHA in different primary immunodeficiencies. J. Immunol. 1982;128:679–683. [PubMed] [Google Scholar]
  14. McGuire K.L., Duncan W.R., Tucker P.W. Syrian hamster DNA shows limited polymorphism at class I-like loci. Immunogenetics. 1985;22:257–268. doi: 10.1007/BF00404485. [DOI] [PubMed] [Google Scholar]
  15. Miller-Edge M., Splitter G. Detection of impaired T cell-mediated immune responses to herpesvirus (BHV-1) in cattle. Vet. Immunopathol. 1986;13:1–18. doi: 10.1016/0165-2427(86)90044-9. [DOI] [PubMed] [Google Scholar]
  16. O'Brien S.J., Wildt D.E., Goldman D., Merril C.R., Bush M. The cheetah is depauperate in genetic variation. Science. 1983;221:459–462. doi: 10.1126/science.221.4609.459. [DOI] [PubMed] [Google Scholar]
  17. O'Brien S.J., Roelke M.E., Marker L., Newman A., Winkler C.A., Meltzer D., Colly L., Evermann J.F., Bush M., Wildt D.E. Genetic basis for species vulnerability in the cheetah. Science. 1985;227:1428–1434. doi: 10.1126/science.2983425. [DOI] [PubMed] [Google Scholar]
  18. Ogilvie G.K., Tompkins M.B., Tompkins W.A.F. Clinical and immunologic aspects of FeLV-induced immunosuppression. Vet. Microbiol. 1988;17:287–296. doi: 10.1016/0378-1135(88)90070-3. [DOI] [PubMed] [Google Scholar]
  19. Paetkau V., Shaw J., Caplan B., Mills G.B., Lee K.-C. Interleukin 2 in cell-mediated immune responses. J. Supramol. Struct. 1980;13:271–280. doi: 10.1002/jss.400130214. [DOI] [PubMed] [Google Scholar]
  20. Pfeifer M.L., Evermann J.F., Roelke M.E., Gallina A.M., Ott R.L., McKeirnan A.J. Feline infectious peritonitis in a captive cheetah. J. Am. Vet. Med. Assoc. 1983;183:1317–1319. [PubMed] [Google Scholar]
  21. Rabin H., Hopkins R.F., III, Ruscetti F.W., Neubauer R.H., Brown R.L., Kawakami T.G. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 1981;127:1852–1856. [PubMed] [Google Scholar]
  22. Ruscetti F.W., Gallo R.C. Humans T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. Blood. 1981;57:379–394. [PubMed] [Google Scholar]
  23. Scherba G., Hajjar A.M., Pernikoff D.S., Sundberg J.P., Basgall E.J., Leon-Monzon M., Nerurkar L., Reichmann M.E. Comparison of a cheetah herpesvirus isolate to feline herpesvirus type 1. Arch. Virol. 1988;100:89–97. doi: 10.1007/BF01310910. [DOI] [PubMed] [Google Scholar]
  24. Smith W.G., Usinger W.R., Splitter G.A. Bovine Con A-induced suppressor cells: generation, macrophage requirements and possible mechanisms of regulatory action. Immunology. 1981;43:91–100. [PMC free article] [PubMed] [Google Scholar]
  25. Stott J.L., Fenwick B.W., Osburn B.I. Human recombinant interleukin-2 augments in vitro blastogenesis of bovine and porcine lymphocytes. Vet. Immunol. Immunopathol. 1986;13:31–38. doi: 10.1016/0165-2427(86)90046-2. [DOI] [PubMed] [Google Scholar]
  26. Tompkins M.B., Tompkins W.A.F., Ogilvie G.K. Immunopathogenesis of feline leukemia virus infections. Companion Anim. Pract. 1988;2:15–26. [Google Scholar]
  27. Toolan H.W. Vol. 37. 1978. Susceptibility of the Syrian hamster to virus infection; pp. 2065–2068. (Fed. Proc. Am. Soc. Exp. Biol.). [PubMed] [Google Scholar]
  28. Watkins D.I., Hodi F.S., Letvin N.L. Vol. 85. 1988. A primate species with limited major histocompatibility complex class I polymorphism; pp. 7714–7718. (Proc. Natl. Acad. Sci., USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wu Y., Ernberg I., Masucci M.G., Johnson D., Klein E., Klein G. Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes. J. Immunol. Methods. 1982;51:35–44. doi: 10.1016/0022-1759(82)90379-9. [DOI] [PubMed] [Google Scholar]

Articles from Veterinary Immunology and Immunopathology are provided here courtesy of Elsevier

RESOURCES